» Articles » PMID: 17530189

Proteomic Identification of Differently Expressed Proteins Responsible for Osteoblast Differentiation from Human Mesenchymal Stem Cells

Overview
Publisher Springer
Specialty Biochemistry
Date 2007 May 29
PMID 17530189
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

Human mesenchymal stem cells (hMSC) are a population of multipotent cells that can differentiate into osteoblasts, chondrocytes, adipocytes, and other cells. The exact mechanism governing the differentiation of hMSC into osteoblasts remains largely unknown. Here, we analyzed protein expression profiles of undifferentiated as well as osteogenic induced hMSC using 2-D gel electrophoresis (2-DE), mass spectrometry (MS), and peptide mass fingerprinting (PMF) to investigate the early gene expression in osteoblast differentiation. We have generated proteome maps of undifferentiated hMSC and osteogenic induced hMSC on day 3 and day 7. 2-DE revealed 102 spots with at least 2.0-fold changes in expression and 52 differently expressed proteins were successfully identified by MALDI-TOF-MS. These proteins were classified into 7 functional categories: metabolism, signal transduction, transcription, calcium-binding protein, protein degradation, protein folding and others. The expression of some identified proteins was confirmed by further RT-PCR analyses. This study clarifies the global proteome during osteoblast differentiation. Our results will play an important role in better elucidating the underlying molecular mechanism in hMSC differentiation into osteoblasts.

Citing Articles

TMT-based quantitative proteomic analysis revealed that FBLN2 and NPR3 are involved in the early osteogenic differentiation of mesenchymal stem cells (MSCs).

Liu J, He S, Ma B, Li X, Wang Y, Xiong J Aging (Albany NY). 2023; 15(15):7637-7654.

PMID: 37543430 PMC: 10457061. DOI: 10.18632/aging.204931.


Machine Learning in Automated Monitoring of Metabolic Changes Accompanying the Differentiation of Adipose-Tissue-Derived Human Mesenchymal Stem Cells Employing H-H TOCSY NMR.

Migdadi L, Sharar N, Jafar H, Telfah A, Hergenroder R, Wohler C Metabolites. 2023; 13(3).

PMID: 36984792 PMC: 10055867. DOI: 10.3390/metabo13030352.


SLC38A2 provides proline to fulfill unique synthetic demands arising during osteoblast differentiation and bone formation.

Shen L, Yu Y, Zhou Y, Pruett-Miller S, Zhang G, Karner C Elife. 2022; 11.

PMID: 35261338 PMC: 9007586. DOI: 10.7554/eLife.76963.


Molecular characterisation of osteoblasts from bone obtained from people of Polynesian and European ancestry undergoing joint replacement surgery.

Naot D, Bentley J, Macpherson C, Pitto R, Bava U, Choi A Sci Rep. 2021; 11(1):2428.

PMID: 33510208 PMC: 7844412. DOI: 10.1038/s41598-021-81731-5.


Systems biology analysis of osteogenic differentiation behavior by canine mesenchymal stem cells derived from bone marrow and dental pulp.

Nantavisai S, Pisitkun T, Osathanon T, Pavasant P, Kalpravidh C, Dhitavat S Sci Rep. 2020; 10(1):20703.

PMID: 33244029 PMC: 7692528. DOI: 10.1038/s41598-020-77656-0.


References
1.
Yang J, Rodrigo R, Felipo V, Lubec G . Proteome analysis of primary neurons and astrocytes from rat cerebellum. J Proteome Res. 2005; 4(3):768-88. DOI: 10.1021/pr049774v. View

2.
Maurer M, Feldmann Jr R, Futterer C, Kuschinsky W . The proteome of neural stem cells from adult rat hippocampus. Proteome Sci. 2003; 1(1):4. PMC: 165415. DOI: 10.1186/1477-5956-1-4. View

3.
Foster L, Zeemann P, Li C, Mann M, Jensen O, Kassem M . Differential expression profiling of membrane proteins by quantitative proteomics in a human mesenchymal stem cell line undergoing osteoblast differentiation. Stem Cells. 2005; 23(9):1367-77. DOI: 10.1634/stemcells.2004-0372. View

4.
Taguchi A, Blood D, Del Toro G, Canet A, Lee D, Qu W . Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases. Nature. 2000; 405(6784):354-60. DOI: 10.1038/35012626. View

5.
Loeffler-Ragg J, Skvortsov S, Sarg B, Skvortsova I, Witsch-Baumgartner M, Mueller D . Gefitinib-responsive EGFR-positive colorectal cancers have different proteome profiles from non-responsive cell lines. Eur J Cancer. 2005; 41(15):2338-46. DOI: 10.1016/j.ejca.2005.06.014. View